Axitinib is an indazole derivative. It is most commonly marketed under the name Inlyta® and is available in oral formulations._x000D_ Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).7. Reference standards of Axitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Axitinib galactose adduct [catalogue_number] => PA 28 0451011 [category_ids] => ,70,75,76,78,82,91, [chemical_name] => [weight] => 548.61 [form] => C28H28N4O6S [cas] => NA [pslug] => axitinib-galactose-adduct-pa280451011 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 28 0451011
CAS :
Molecular Formula : C28H28N4O6S
Molecular Weight : 548.61
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
